Overview

Efficacy and Safety of Amodiaquine and Amodiaquine-Artesunate

Status:
Unknown status
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and safety of two antimalarial drug regimes, namely amodiaquine versus amodiaquine-artesunate, in the treatment of children with uncomplicated malaria. Also, genetic host factors which might influence efficacy and/or safety will be examined.
Phase:
Phase 4
Details
Lead Sponsor:
Charite University, Berlin, Germany
Collaborators:
Kintampo Health Research Centre, Ghana
University for Development Studies, Tamale, Ghana
Treatments:
Amodiaquine
Artemisinins
Artesunate